Nautilus Biotechnolgy Inc. logo

Nautilus Biotechnolgy Inc.

NAUT | NASDAQ
Chart Builder DCF Calculator
$1
+$0.05 (+4.74%)
Sep 22, 2026, 1:55 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
12.39M 27.65M 19.4M 114.52M 185.62M 36.61M
Short-Term Investments
91.02M 102.25M 154.02M 69.95M 160.11M 40.14M
Long-Term Investments
52.74M 76.41M 90.65M 129.17M 16.37M n/a
Other Long-Term Assets
1.18M 1.18M 1.18M 1.11M 997K 1.14M
Receivables
n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
2.56M 2.93M 3.42M n/a n/a n/a
Total Current Assets
105.96M 132.83M 176.84M 187.21M 349.22M 77.66M
Property-Plant & Equipment
31.23M 32.33M 36.9M 32.57M 31.86M 6.21M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
85.15M 109.92M 128.73M 162.84M 49.23M 7.35M
Total Assets
191.11M 242.74M 305.57M 350.05M 398.45M 85.01M
Account Payables
943K 987K 1.64M 1.27M 1.72M 470K
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a
Other Current Liabilities
2.7M 1.86M 2.97M 438K 388K 617K
Total Current Liabilities
7.95M 7.63M 9.12M 6.79M 5.81M 3.02M
Long-Term Debt
26.19M n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a 108.42M
Total Long-Term Liabilities
26.19M 26.38M 31.09M 28.34M 29.06M 111.71M
Total Liabilities
34.14M 34.01M 40.21M 35.13M 34.87M 114.73M
Total Debt
30.02M 30.48M 34.63M 30.33M 30.03M 4.78M
Book Value
156.97M 208.73M 265.35M 314.92M 363.58M -29.72M
Book Value Per Share
1.24 1.66 2.12 2.53 4.30 -0.90
Common Stock
13K 13K 13K 12K 12K 1K
Retained Earnings
-332.02M -273.02M -202.24M -138.56M -80.64M -30.33M
Comprehensive Income
243K 57K -255K -1.85M -184K 3K
Shareholders Equity
156.97M 208.73M 265.35M 314.92M 363.58M -29.72M
Total Investments
143.76M 178.65M 244.67M 199.12M 176.48M 40.14M

© 2026 bestshares.com. All rights reserved.